Mylan Drug Patent Portfolio

Mylan owns 3 orange book drugs protected by 8 US patents Given below is the list of Mylan's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9345772 Liquid levothyroxine formulations 27 Feb, 2035
Active
US8147852 Modified azole compounds as antifungal and antibacterial agents 30 Mar, 2028
Active
US6579981 Antiviral guanine derivatives 17 Jun, 2020 Expired
US6469015 Pharmaceutical formulation 22 Oct, 2019 Expired
US5840763 Treatment of a latent infection of herpes viruses 01 Sep, 2015 Expired
US5916893 Treatment of a latent infection of herpes virus 01 Sep, 2015 Expired
US5866581 Penciclovir for the treatment of post therapeutic neuralgia 04 Oct, 2014 Expired
US6124304 Penciclovir for the treatment of zoster associated pain 04 Oct, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Mylan.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 19 Sep, 2023 US8147852
Email Notification 16 May, 2022 US8147852
Change in Power of Attorney (May Include Associate POA) 16 May, 2022 US8147852
Correspondence Address Change 13 May, 2022 US8147852
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 26 Sep, 2019 US8147852
Payment of Maintenance Fee, 8th Year, Large Entity 26 Sep, 2019 US8147852
Email Notification 14 Nov, 2016 US8147852
Change in Power of Attorney (May Include Associate POA) 14 Nov, 2016 US8147852
Correspondence Address Change 10 Nov, 2016 US8147852
Change in Power of Attorney (May Include Associate POA) 06 May, 2016 US8147852
Email Notification 06 May, 2016 US8147852
Correspondence Address Change 05 May, 2016 US8147852
Post Issue Communication - Certificate of Correction 19 Jun, 2012 US8147852
Recordation of Patent Grant Mailed 03 Apr, 2012 US8147852
Patent Issue Date Used in PTA Calculation 03 Apr, 2012 US8147852


Mylan's Drug Patent Litigations

Mylan's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 14, 2000, against patent number US6579981. The petitioner , challenged the validity of this patent, with JARVEST et al as the respondent. Click below to track the latest information on how companies are challenging Mylan's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8147852 November, 2010 Decision
(08 Aug, 2011)
Marcel Borgers et al
US6579981 January, 2000 Decision
(26 Sep, 2002)
JARVEST et al
US6579981 January, 2000 Decision
(04 Jul, 1776)
JARVEST et al


Mylan's Family Patents

Mylan drugs have patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click below to unlock the full patent family tree.

Family Patents



Mylan Drug List

Given below is the complete list of Mylan's drugs and the patents protecting them.


1. Denavir

Denavir is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6579981 Antiviral guanine derivatives 17 Jun, 2020
(4 years ago)
Expired
US6469015 Pharmaceutical formulation 22 Oct, 2019
(4 years ago)
Expired
US5840763 Treatment of a latent infection of herpes viruses 01 Sep, 2015
(9 years ago)
Expired
US5916893 Treatment of a latent infection of herpes virus 01 Sep, 2015
(9 years ago)
Expired
US5866581 Penciclovir for the treatment of post therapeutic neuralgia 04 Oct, 2014
(10 years ago)
Expired
US6124304 Penciclovir for the treatment of zoster associated pain 04 Oct, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Denavir's drug page


2. Ermeza

Ermeza is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9345772 Liquid levothyroxine formulations 27 Feb, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ermeza's drug page


3. Vusion

Vusion is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8147852 Modified azole compounds as antifungal and antibacterial agents 30 Mar, 2028
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vusion's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Mylan News

Report: U.S. Aims to Eliminate HIV Epidemic by 2034 in the HIV Drugs and Injectables Market

09 Aug, 2024

See More